Aston Sci. Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $27.6M

  • Investors
  • 19

Aston Sci. General Information

Description

Developer of immunotherapy products designed to develop therapeutic cancer vaccines and proteostasis modulators. The company focuses on basic research and clinical development of therapeutic cancer vaccines, anticancer drugs that regulate protein metabolism in cancer cells, and therapies for immune-related and age-related diseases, enabling healthcare providers to access targeted immunotherapies for oncology and immunology applications.

Contact Information

Website
www.astonsci.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • A916-917, C-dong
  • 520, Misa-daero
  • Hanam-Si, Gyeonggi 12925
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • A916-917, C-dong
  • 520, Misa-daero
  • Hanam-Si, Gyeonggi 12925
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aston Sci. Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series D) 20-Aug-2026 $27.6M Completed Clinical Trials - Phase 2
5. Later Stage VC (Series C) 11-Jan-2022 Completed Clinical Trials - Phase 2
4. Early Stage VC 01-Aug-2021 Completed Clinical Trials - Phase 2
3. Early Stage VC (Series B) 01-Nov-2020 Completed Startup
2. Early Stage VC (Series A) 01-Nov-2019 Completed Startup
1. Seed Round 31-Oct-2018 Completed Startup
To view Aston Sci.’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Aston Sci. Patents

  • 20

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 10

    Pending

  • Expiring in next 12 mo

Aston Sci. Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4491626-A1 Phenylsulfonamide derivatives, preparation method therefor, and pharmaceutical composition for prevention or treatment of cancer containing same as active ingredient Inactive 08-Jun-2022
US-20260184706-A1 Phenylsulfonamide derivatives, preparation method therefor, and pharmaceutical composition for prevention or treatment of cancer containing same as active ingredient Pending 08-Jun-2022
WO-2023239165-A1 Phenylsulfonamide derivatives, preparation method therefor, and pharmaceutical composition for prevention or treatment of cancer containing same as active ingredient Inactive 08-Jun-2022
EP-4410305-A1 Anticancer vaccine composition comprising hsp90 antigenic peptide and use thereof Inactive 29-Sep-2021
US-20250319172-A1 Anticancer vaccine composition comprising hsp90 antigenic peptide and use thereof Pending 29-Sep-2021 A61K39/001176
To view Aston Sci.’s complete patent history, request access »

Aston Sci. Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aston Sci. Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds
CKD Venture Capital Corporate Venture Capital Minority
Kolon Investment Venture Capital Minority
Korea Development Bank VC-Backed Company Minority
Korea Investment Partners Venture Capital Minority
Mint Venture Partners Accelerator/Incubator Minority
You’re viewing 5 of 19 investors. Get the full list »

Ready to get started?

Request a free trial

Aston Sci. FAQs

  • When was Aston Sci. founded?

    Aston Sci. was founded in 2018.

  • Where is Aston Sci. headquartered?

    Aston Sci. is headquartered in Hanam-Si, South Korea.

  • What is the size of Aston Sci.?

    Aston Sci. has 12 total employees.

  • What industry is Aston Sci. in?

    Aston Sci.’s primary industry is Drug Discovery.

  • Is Aston Sci. a private or public company?

    Aston Sci. is a Private company.

  • What is Aston Sci.’s current revenue?

    The current revenue for Aston Sci. is .

  • How much funding has Aston Sci. raised over time?

    Aston Sci. has raised $50.3M.

  • Who are Aston Sci.’s investors?

    CKD Venture Capital, Kolon Investment, Korea Development Bank, Korea Investment Partners, and Mint Venture Partners are 5 of 19 investors who have invested in Aston Sci..

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process